Recently, Abiochem's steviol glycosides were successfully included in the fourteenth batch of the "Shanghai Innovative Product Recommendation Catalog." This catalog, jointly issued by the Shanghai Municipal Commission of Economy and Informatization and the Municipal Science and Technology Commission, serves as an authoritative certification system in Shanghai's scientific innovation sector. This selection highlights the company's strong innovative capabilities in the field of bio-intelligent manufacturing.

Adorvia, an independently operated subsidiary of the Abiochem Group focused on the sweetener business, has achieved significant technological breakthroughs with its steviol glycosides product. In natural stevia plants, the content of this component is only about 1%, and traditional extraction methods face challenges of high costs and low yields. Leveraging its eight synthetic biology technology platforms, Abiochem has achieved a breakthrough purity of 98%–99% through an exclusive enzymatic conversion method, effectively overcoming raw material scarcity and driving the industrial upgrade of high-end sweetener production from "plant dependence" to "bio-intelligent manufacturing."

The product has secured important market access qualifications, becoming the first and only product of its kind in China approved by the National Health Commission. It also obtained FDA GRAS certification in the United States earlier this year. Currently, its applications span over ten categories in the food industry, including beverages, dairy products, candies, biscuits, and baked goods, demonstrating promising market prospects.

The selection process for the "Shanghai Innovative Product Recommendation Catalog" emphasizes multiple dimensions such as technological innovation, industrial application capabilities, and industry leadership. Abiochem's inclusion not only affirms the company's innovative strengths but will also provide significant support for the product's future promotion and industrialization process.

Moving forward, Adorvia will continue to serve as a key component of the Abiochem Group's strategic layout. Adhering to an innovation-driven development strategy, the company is committed to providing more green and efficient solutions for industries such as food and health through advanced biotechnology, contributing to the development of the biomanufacturing sector in Shanghai and across China.